Quarterly Balance Sheet

Carna Biosciences, Inc. - Filing #7338599

Concept As at
2024-03-31
As at
2023-12-31
Quarterly balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
3,159,233,000 JPY
2,889,101,000 JPY
Merchandise and finished goods
94,799,000 JPY
94,383,000 JPY
Work in process
11,360,000 JPY
12,390,000 JPY
Raw materials and supplies
35,470,000 JPY
33,367,000 JPY
Other
357,661,000 JPY
374,044,000 JPY
Current assets
3,743,627,000 JPY
4,191,484,000 JPY
Non-current assets
Property, plant and equipment
105,440,000 JPY
105,498,000 JPY
Property, plant and equipment
Intangible assets
885,000 JPY
1,091,000 JPY
Intangible assets
Investments and other assets
44,266,000 JPY
51,817,000 JPY
Investments and other assets
Non-current assets
150,593,000 JPY
158,407,000 JPY
Assets
3,894,220,000 JPY
4,349,891,000 JPY
Liabilities
Current liabilities
Income taxes payable
11,733,000 JPY
28,273,000 JPY
Other
27,917,000 JPY
36,349,000 JPY
Current liabilities
273,260,000 JPY
375,921,000 JPY
Non-current liabilities
Long-term borrowings
23,404,000 JPY
28,402,000 JPY
Asset retirement obligations
38,815,000 JPY
38,657,000 JPY
Other
40,770,000 JPY
29,375,000 JPY
Non-current liabilities
102,989,000 JPY
96,435,000 JPY
Liabilities
376,249,000 JPY
472,356,000 JPY
Net assets
Shareholders' equity
Share capital
2,076,474,000 JPY
2,076,474,000 JPY
Capital surplus
5,827,683,000 JPY
5,827,683,000 JPY
Retained earnings
-4,474,276,000 JPY
-4,075,386,000 JPY
Treasury shares
-222,000 JPY
-222,000 JPY
Shareholders' equity
3,429,658,000 JPY
3,828,549,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-2,952,000 JPY
-2,722,000 JPY
Deferred gains or losses on hedges
19,240,000 JPY
JPY
Valuation and translation adjustments
88,313,000 JPY
48,986,000 JPY
Net assets
3,517,971,000 JPY
3,877,535,000 JPY
Liabilities and net assets
3,894,220,000 JPY
4,349,891,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.